MREO vs GILD: Which Stock is Better?
Side-by-side comparison of Mereo BioPharma Group PLC ADR and Gilead Sciences Inc in 2026
MREO
Mereo BioPharma Group PLC ADR
$0.57
GILD
Gilead Sciences Inc
$124.14
Key Metrics Comparison
| Metric | MREO | GILD | Winner |
|---|---|---|---|
| Market Cap | $89.93M | $154.03B | GILD |
| P/E Ratio | N/A | 19.22 | GILD |
| EPS (TTM) | $N/A | $6.46 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 73.4% | 78.7% | GILD |
Analyze MREO
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MREO or GILD a better investment?
Comparing MREO and GILD: Mereo BioPharma Group PLC ADR has a market cap of $89.93M while Gilead Sciences Inc has $154.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MREO and GILD?
MREO (Mereo BioPharma Group PLC ADR) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MREO or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: MREO or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for MREO.
Which company is more profitable: MREO or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.7% compared to 73.4% for MREO.
Which is the larger company: MREO or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $154.03B compared to $89.93M for MREO.
Should I buy MREO or GILD in 2026?
Both MREO and GILD have investment merit. MREO trades at $0.57 while GILD trades at $124.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MREO and GILD stock?
Key differences: Market Cap ($89.93M vs $154.03B), P/E Ratio (N/A vs 19.2x), Revenue Growth (0.0% vs 0.0%), Gross Margin (73.4% vs 78.7%).